261 related articles for article (PubMed ID: 30219716)
1. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
[TBL] [Abstract][Full Text] [Related]
2. Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutation.
Meraviglia V; Ganesh S; Arendzen CH; Freund C; Sommariva E; Rossini A; Bellin M
Stem Cell Res; 2021 Jul; 54():102426. PubMed ID: 34134068
[TBL] [Abstract][Full Text] [Related]
3. Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.
Meraviglia V; Arendzen CH; Tok M; Freund C; Maione AS; Sommariva E; Bellin M
Stem Cell Res; 2020 Jul; 46():101835. PubMed ID: 32485643
[TBL] [Abstract][Full Text] [Related]
4. Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.
Amin G; Castañeda SL; Zabalegui F; Belli C; Atorrasagasti C; Miriuka SG; Moro LN
Stem Cell Res; 2023 Sep; 71():103157. PubMed ID: 37393721
[TBL] [Abstract][Full Text] [Related]
5. Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation.
Zhou D; Sun Y; Shen J; Su J; Gong T; Jiang C; Liang P
Stem Cell Res; 2020 Oct; 48():101965. PubMed ID: 32916635
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA).
Yang J; Samal E; Burgos Angulo M; Bertalovitz A; McDonald TV
Stem Cell Res; 2021 Jul; 54():102398. PubMed ID: 34034221
[TBL] [Abstract][Full Text] [Related]
8. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene.
Jahng JWS; Black KE; Liu L; Bae HR; Perez M; Ashley EA; Sallam K; Wu JC
Stem Cell Res; 2021 May; 53():102284. PubMed ID: 33743362
[TBL] [Abstract][Full Text] [Related]
9. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
[TBL] [Abstract][Full Text] [Related]
10. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of three human induced pluripotent stem cell lines (EURACi007-A, EURACi008-A, EURACi009-A) from three different individuals of the same family with arrhythmogenic cardiomyopathy (ACM) carrying the plakophillin2 p.N346Lfs*12 mutation.
Meraviglia V; Cattelan G; De Bortoli M; Motta BM; Volpato C; Frommelt LS; Rauhe W; Di Segni M; Silipigni R; Pramstaller PP; Rossini A
Stem Cell Res; 2021 Aug; 55():102466. PubMed ID: 34298432
[TBL] [Abstract][Full Text] [Related]
12. [Generation of induced pluripotent stem cells from arrhythmogenic right ventricular disease patient].
Jiang B; Wang GQ; Li HX; Jiang WP; Chen T; Jiang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):503-507. PubMed ID: 29931898
[TBL] [Abstract][Full Text] [Related]
13. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.
Sommariva E; Brambilla S; Carbucicchio C; Gambini E; Meraviglia V; Dello Russo A; Farina FM; Casella M; Catto V; Pontone G; Chiesa M; Stadiotti I; Cogliati E; Paolin A; Ouali Alami N; Preziuso C; d'Amati G; Colombo GI; Rossini A; Capogrossi MC; Tondo C; Pompilio G
Eur Heart J; 2016 Jun; 37(23):1835-46. PubMed ID: 26590176
[TBL] [Abstract][Full Text] [Related]
14. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy.
Tsui H; van Kampen SJ; Han SJ; Meraviglia V; van Ham WB; Casini S; van der Kraak P; Vink A; Yin X; Mayr M; Bossu A; Marchal GA; Monshouwer-Kloots J; Eding J; Versteeg D; de Ruiter H; Bezstarosti K; Groeneweg J; Klaasen SJ; van Laake LW; Demmers JAA; Kops GJPL; Mummery CL; van Veen TAB; Remme CA; Bellin M; van Rooij E
Sci Transl Med; 2023 Mar; 15(688):eadd4248. PubMed ID: 36947592
[TBL] [Abstract][Full Text] [Related]
15. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
16. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
[TBL] [Abstract][Full Text] [Related]
17. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene.
Khudiakov A; Zaytseva A; Perepelina K; Smolina N; Pervunina T; Vasichkina E; Karpushev A; Tomilin A; Malashicheva A; Kostareva A
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165915. PubMed ID: 32768677
[TBL] [Abstract][Full Text] [Related]
18. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
20. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
Inoue H; Nakamura S; Higo S; Shiba M; Kohama Y; Kondo T; Kameda S; Tabata T; Okuno S; Ikeda Y; Li J; Liu L; Yamazaki S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Stem Cell Reports; 2022 Feb; 17(2):337-351. PubMed ID: 35063130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
